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ABSTRACT
Objective: To evaluate the safety and efficacy of unilateral Gamma Knife thalamotomy (GKT) for
treatment of severe tremor with a prospective blinded assessment.
Methods: Fifty patients (mean age: 74.5 years; 32 men) with severe refractory tremor (36 essen-
tial, 14 parkinsonian) were treated with unilateral GKT. Targeting of the ventral intermediate
nucleus (Vim) was achieved with Leksell Gamma Knife with a single shot through a 4-mm collima-
tor helmet. The prescription dose was 130 Gy. Neurologic and neuropsychological assessments
including a single-blinded video assessment of the tremor severity performed by a movement dis-
orders neurologist from another center were performed before and 12 months after treatment.
MRI follow-up occurred at 3, 6, and 12 months.
Results: The upper limb tremor score improved by 54.2% on the blinded assessment (p ,
0.0001). All tremor components (rest, postural, and intention) were improved. Activities of daily
living were improved by 72.2%. Cognitive functions remained unchanged. Following GKT, the
median delay of improvement was 5.3 months (range 1–12 months). The only side effect was a
transient hemiparesis associated with excessive edema around the thalamotomy in one patient.
Conclusion: This blinded prospective assessment demonstrates that unilateral GKT is a safe and
efficient procedure for severe medically refractory tremor. Side effects were rare and transient in
this study.
Classification of evidence: This study provides Class IV evidence that for patients with severe
refractory tremor, GKT is well tolerated and effective in reducing tremor impairment.
Neurology® 2015;85:1562–1568
GLOSSARY
AC-PC 5 anterior commissure–posterior commissure; ADL 5 activities of daily living; DBS 5 deep brain stimulation; ET 5
essential tremor;GK5Gamma Knife; GKT5 Gamma Knife thalamotomy; IP5 improved patient; NIP5 nonimproved patient;
PD 5 Parkinson disease; RFT 5 radiofrequency thermocoagulation; Vim 5 ventral intermediate nucleus.
The pharmacologic treatment for severe tremor can be disappointing.1,2 Stereotactic surgery,
such as radiofrequency thermocoagulation (RFT) or deep brain stimulation (DBS), may be a
therapeutic option.3–5 DBS has supplanted RFT as the reference technique because of its effi-
cacy, potential reversibility, adaptability, and safety even when performed bilaterally.2,6–11 How-
ever, both RFT and DBS may carry significant risks including intracerebral hemorrhage,
infection, and hardware-related complications. Both techniques may also be contraindicated
in some conditions (anticoagulant medication, comorbidities, or very advanced age).
Gamma Knife (GK) radiosurgery is a minimally invasive neurosurgical procedure without
craniotomy and therefore no risk of intracranial infection or bleeding. Since the first 1992 pub-
lication,12 several studies13–17 have reported the efficacy of GK thalamotomy (GKT) on severe
tremor (essential tremor [ET] and tremor-dominant Parkinson disease [PD]) with a low rate of
complications. However, as highlighted in a recent review,18 the level of evidence is weak and
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suffers from being mainly based on retrospec-
tive cohort studies, a single prospective study
with no independent evaluation, and only one
single-blind study on 14 patients.13–17,19 These
studies comprise significant flaws.2,18 An accu-
rate independent and blinded assessment of
tremor control is a critical step in determining
whether the procedure is successful.
The aim of this study was to prospectively
assess the efficacy of unilateral GKT in a large
group of patients with severe tremor using
blinded video assessments, in addition to the
evaluation of activities of daily living (ADL),
neuropsychological testing, and neuroimaging
assessments.
METHODS The study was designed to provide Class IV evi-
dence that for patients with severe refractory tremor, GKT is well
tolerated and effective in reducing tremor. Between September
2004 and September 2010, 61 consecutive patients, referred to
Timone University Hospital in Marseille from several French
Movement Disorders departments, were prospectively evaluated
and underwent unilateral GKT for treatment of medically refrac-
tory essential or parkinsonian tremor. Patients were included if
they had severe disabling tremor of one or both upper limbs, if
they could not undergo Vim DBS for any medical or surgical rea-
sons, or if they were refusing DBS. Patients younger than 18
years, patients unable to fully understand and give their consent
to the therapeutic proposal because of cognitive or psychiatric
conditions, and patients with abnormal anatomy of their thalamic
area were excluded. There was no maximum age limitation.
Eleven patients were unable to complete the 12-month
follow-up (7 patients were lost to follow-up, 3 were hospitalized
for concomitant disease, and one refused the last video assess-
ment) and were excluded from the main analysis. The main dif-
ficulties for follow-up were the advanced age of the patients and
the fact that many patients (41%) lived far away from Marseille.
Some follow-up data could be retrieved for 9 of these patients
(medical records, telephone call, etc.); table e-1 on the
Neurology® Web site at Neurology.org gives the details on this
informal follow-up.
Two patients with PD had previously (12 and 15 years ear-
lier) undergone unilateral Vim DBS. With the emergence of
severe contralateral upper limb tremor, a GKT was proposed,
their advanced age contraindicating a contralateral DBS lead
implantation. One patient with ET and bilateral Vim DBS had
left GKT after leads were removed due to hardware infection.
Demographic data and clinical characteristics of all patients are
shown in table 1.
Assessments were prospectively performed before GKT and at
6 and 12 months following radiosurgery. Tremor severity of the
upper limbs was assessed according to the Fahn-Tolosa-Marin
Tremor Rating Scale20 and item “drinking from a cup” from
the Washington Heights–Inwood Genetic Study of Essential
Tremor Rating Scale.21 The Tremor Rating Scale items included
resting, postural, and action/intention tremor using the finger-to-
nose test (for each of these items, scores ranged from 0 5 no
tremor to 4 5 severe tremor, with amplitude .4 cm); handwrit-
ing (0 5 normal; 4 5 severely abnormal, unable to keep pen on
paper without holding the hand down); drawing (Archimedes
spirals A large); and pouring water from one cup to another
(0 5 normal, 4 5 unable to pour water without spilling most
of it) and drinking from a cup (0 5 normal, 4 5 unable to hold
the cup). The global tremor score was calculated as the sum of the
above-mentioned items (total score 5 28 if writing was consid-
ered, 24 if not). For items in which both sides were scored, only
the side contralateral to the thalamotomy was taken into account.
The tremor severity was assessed without interrupting the med-
ication. The assessments were performed by the same neurologist
(T.W.) who did the video recordings for the 50 patients. ADLs
were assessed using a self-questionnaire designed by Bain (25 items,
score 1: able to do the activity without difficulty; 4: cannot do the
activity).22 Cognitive performances were assessed using Mattis
Dementia Rating Scale and verbal fluency test. Five patients were
not able to complete a full neuropsychological testing because of
language barrier (2 patients), severe upper limb and voice tremor (2
patients), and refusal to do the assessment at 12 months (1 patient).
An independent movement disorders neurologist (P.K.) as-
sessed the tremor severity score by viewing videos of each patient
before and at 1 year after unilateral GKT in a randomized,
blinded manner concerning both the laterality of the thalamot-
omy and the state of the patient (before or after treatment).
The video-based tremor evaluation scored the following items
(from 0 to 4): rest, postural (both arms outstretched), intention
(finger to nose), Archimedes spiral drawing, handwriting, drink-
ing, and pouring a glass of water (total score on 28). The tremor
score was performed only in the upper limbs. Blinded assessment
of voice, head, or lower limb action tremor on walking was not
analyzed because unilateral GKT is known to have little or no
effect on axial symptoms. Moreover, these features are more dif-
ficult to rate reliably based on video assessment and the upper
limb tremor was the predominant symptom in all the patients.
Serial MRIs were obtained at 3, 6, and 12 months after radi-
osurgery. The radiosurgical procedures were all performed by the
same neurosurgeon (J.R.). Patients, in agreement with their
choice, were unilaterally treated on the contralateral side of the
most disabled limb. The Leksell G frame was applied under local
anesthesia. Special care was taken to place the stereotactic frame
parallel to the orientation of the anterior commissure–posterior
commissure (AC-PC) line and to minimize head tilt or rotation.
Table 1 Patient characteristics
No. of patients 50
Male/female 32/18
Handedness 46 R/4 L
Age at GK treatment, y 74.5 (60–91)a
Disease duration, y 22.4 (4–74)a
Etiology of tremor 36 ET/14 PD
Treated Vim 38 left Vim/12
right Vim
Major factors in the decision to use
GK thalamotomy rather than DBS
Medical comorbidities 25
Advanced age (>75 y) 17
Patient refusal of DBS (age <75 y) 8
Abbreviations: DBS 5 deep brain stimulation; ET 5 essen-
tial tremor; PD 5 Parkinson disease; Vim 5 ventral interme-
diate nucleus.
aRange.
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Stereotactic imaging consisted of an axial T2-weighted half-
millimetric acquisition (CISS [Constructive Interference in
Steady State], 1.5T; Siemens, Erlangen, Germany) at the level
of AC-PC providing a magnetic resonance “ventriculography”
of the third ventricle, a turbo spin-echo coronal 3 mm thick at
the level of thalamus, and a T1-weighted 3-dimensional acquisi-
tion (magnetization-prepared rapid-acquisition gradient
echo,1.5T; Siemens). An additional stereotactic CT scan was sys-
tematically performed and coregistered to rule out any potential
distortion of the MRI scans.
Treatment planning was performed with Leksell Gamma
Plan software (8.3.1 up to 10.1.1 version) (Elekta, Stockholm,
Sweden). Nonstereotactic images, including diffusion tensor im-
ages acquired before the treatment, were fused with the stereotac-
tic ones. AC and PC were defined on the magnetic resonance
ventriculography. The center of the target, determined according
to Guiot’s diagram, was placed 2.5 mm above the AC-PC line, 11
mm lateral to the wall of the third ventricle, and at a mean of
7.3 mm in front of the PC (3.9–9.9; SD: 1.33).
A unique 4-mm isocenter was used, as well as beam blocking
to optimize the gradient of dose toward the internal capsule. The
prescription dose was 130 Gy (maximum dose) in all patients.
The patient was discharged the day after the radiosurgical proce-
dure. The evolution of the GK radiosurgical lesion within the
Vim was analyzed for all the patients by the same neurosurgeon
(R.C.) who was blinded to the clinical results.
Descriptive statistics are reported in the text as median and
interquartile interval in parenthesis (Q3–Q1) except the results
for each subscore of the tremor (mean 6 SEM). To explore the
GK effect, the comparisons between scores before and at 12
months after GK were tested using Wilcoxon signed rank test.
The percentage of improvement both for tremor severity and
ADL was obtained based on the difference between these scores
assessed at baseline and at 1 year after radiosurgery. Weighted k
was used to assess interrater reliability measured for both global
and subscores.23 The relationship between the ADL improvement
and the symptomatic amelioration rates was investigated using
the Spearman correlation. Differences with a p value,0.05 were
considered to be statistically significant.
Standard protocol approvals, registrations, and patient
consents. All patients participated with informed written con-
sent. The study was allowed by the local ethics committee, and
was in compliance with the national legislation and the Declara-
tion of Helsinki.
RESULTS Medians and interquartile intervals of the
tremor score improvement are presented in figure 1 for
both assessments, blinded and unblinded. The
unblinded assessment showed an improvement of the
global tremor score by 63.40% (38.3–90.6) (W 5
1,248, p, 0.0001) as well as an improvement of each
subscore. The blinded assessment demonstrated an
improvement in the upper limb tremor score by
54.2% (36.2–79.2) (W 5 1,159, p , 0.0001) as well
as an improvement of each subscore (figure 2). The
unblinded assessment of the ipsilateral limb and axial
features showed no significant improvement.
Interrater reliability. The k coefficient for the total
score between blinded and unblinded assessments
was 0.74 (95% confidence interval 0.66–0.82) before
the treatment and 0.78 (95% confidence interval
0.72–0.85) 12 months after unilateral GKT. These
results indicate in both cases a good interrater relia-
bility.23 Globally for all subscores, before as well as
after GKT, the statistical analysis revealed a good
strength of agreement between both raters. Therefore,
all tremor scores used hereafter are based on the
blinded assessment.
The mean improvement in ADL was 72.2% (0%–
100%). To assess whether the ADL improvement was
a good index to evaluate the treatment effect, we cor-
related the ADL improvement with the global tremor
score and subscore improvements according to the
blinded assessment. We found that the tremor score
improvement was correlated with the ADL improve-
ment (r 5 0.68; p , 0.0001). To determine the
functional outcome of GKT, we divided the cohort
into 2 groups according to ADL improvement:
improved patients (IPs) ($50%) and nonimproved
Figure 1 Pre- and post-GK comparison
(A) Tremor score improvement for the blinded and unblinded
assessments. (B) Effect of treatment. The boxes extend
from the first to third quartiles. The lines in the middle rep-
resent the medians. The whiskers go down to the smallest
value and up to the largest. ***p , 0.001. After unilateral
GK thalamotomy, there was a significant improvement in
the upper limb tremor score whatever the item considered.
GK 5 Gamma Knife.
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patients (NIPs) (,50%). We found that 38 patients
were improved (median ADL improvement 96.4%
[87.5%–100%]) and 12 were nonimproved (median
ADL improvement 0% [5.9%–15.2%]). These 38
IPs improved their global tremor score by 64.9%
(range 50%–86%). It is noteworthy that before GK
treatment, there was no difference in tremor severity
between the 2 groups (median 21 [14.8–25] and 17
[14–22] for NIPs and IPs, respectively). Neither the
tremor etiology (PD or ET) nor the tremor score
severity influenced the outcome.
Of the 9 patients lost to follow-up for whom some
follow-up data could be retrieved, the tremor was
deemed significantly reduced for 5 (table e-1).
The delay before any improvement could be iden-
tified by the patient varied usually between 4 and 6
months, with a range of 1 to 12 months (median
5.3) after radiosurgery.
The neuropsychological assessment did not reveal
any significant change in Mattis Dementia Rating
Scale: 135/144 (132–137) pre-GKT and 134 (131–
139) 12 months after GKT. There was a slight non-
significant decrease in literal fluency (15 [11–17] vs
11 [8–17.3]) but a significant decrease in semantic
fluency (25 [19.5–30] vs 22 [17–28]; W5 169; p ,
0.0252).
Concerning side effects, one patient developed a
hemiparesis contralaterally to the thalamotomy at
12 months. This motor deficit regressed and the
patient recovered spontaneously within 3 weeks with-
out any neurologic sequelae and without any steroid
prescription. He had no tremor afterward. The 2 pa-
tients with PD and previous DBS contralateral to
GKT did not experience any adverse event due to
the procedure. The patient with ET who had previ-
ous bilateral DBS had an improvement of his tremor
score by 45.7% after left GKT. His ADLs were
improved by 66.7%. Before the stimulation lead
was removed due to infection, he reported an 85%
improvement of his tremor score with DBS.
Imaging follow-up analysis. Thirty-eight of the 50 pa-
tients had a normal neuroimaging pattern of
response defined as T2-weighted and fluid-
attenuated inversion recovery hyperintense limited
signal changes and a postcontrast ring-shaped lesion
at 12 months (figures 3 and e-1A). One patient had
an excessive response (magnetic resonance scan
showing an abnormally large area of enhancement
with massive edema extending beyond the internal
capsule) that resolved thereafter (figure e-1B). For 11
patients, imaging analysis showed either the absence of
visible lesion or very minimal alterations. All 38
clinically improved patients had a normal (or hyper
for one) neuroimaging pattern. Of the 12 NIPs, one
had a normal radiologic response with correct
stereotactic targeting whereas 11 patients displayed
no or minimal changes (figure e-1C).
DISCUSSION The present prospective study with an
independent and single-blinded video assessment of
50 patients, mean age of 75 years (60–91), with
severe essential (n 5 36) or PD-related (n 5 14)
tremor demonstrates that GKT safely and effectively
reduces disabling upper limb tremor. The global
tremor score improved by 54.2% on blinded
evaluation and ADL by 72.2% 1 year after
unilateral thalamotomy. ADL improved by 50% or
more in 38 patients (76%), and the improvement of
the global tremor score in these patients was 64.9%.
These results are in line with previous studies on
GKT for severe tremor.14,15,17 The experience of
GK radiosurgery for movement disorders started as
early as the 1960s with 470 procedures reported in
more than 70 studies to date. Most of them reported
good efficacy on tremor (60%–90% improvement)
with a low rate of side effects (,8%).14,15,17 The
positive effect of GKT is sustained over time.15
However, these data were criticized because they
were mostly uncontrolled case series.18 The only
study with a blinded assessment was conducted on
Figure 2 Pre- and post-GK comparison of the subscores for blinded assessments
Mean and SEM of each subscore. ***p, 0.001. All subscores improved after radiosurgery as compared with before radiosurgery for the blinded rater. GK5
Gamma Knife.
Neurology 85 November 3, 2015 1565
ª 2015 American Academy of Neurology. Unauthorized reproduction of this article is prohibited.
14 patients with a variable follow-up (range 7–30
months).19 The effect of GKT in this series was in
stark contrast to the rest of the literature. The authors
reported no significant tremor reduction but an
improvement in ADL. However, the follow-up (,1
year) for some patients was probably too short to
conclude for inefficacy. In our experience, the delay
of efficacy can be as long as 1 year as previously
reported. The discrepancy between this series and
the rest of the literature has emphasized the need
for a prospective large cohort study with an
independent and blinded assessment.
GKT is less invasive than open skull neurosurgical
procedures. Adverse events consist of motor deficit,
paraesthesia, or dysarthria with a rate ranging from
1.6% to 8.4%. In a study with blinded assessments,
the authors19 reported 3 adverse events: 2 mild (non-
disabling lip and finger numbness at 18 and 19
months) and one severe (thalamic hemorrhage at 14
months). In the present study, only one patient (2%)
had a transient side effect, consisting of hemiparesis,
associated with marked alterations on the MRI. The
deficit resolved spontaneously within 3 weeks. This
side effect was the consequence of a hyperresponse to
radiosurgery. A Japanese study has reported that
approximately 10% of the patients may have a hyper-
response upon imaging with associated clinical side
effects.14 However, these side effects are reported to
be transient in most cases with no or minimal seque-
lae.17 Eleven patients (18%) could not complete the
follow-up. This relatively high dropout rate may be
explained by the fact that patients were referred from
centers all over France and this elderly population
with comorbidities was not always able to travel.
However, some follow-up data could be retrieved
for 9 patients. Although this is a limitation inherent
to the study design, we believe that the subjective
assessments obtained indicate that most of these pa-
tients also improved.
One challenge with GKT is the variability of the
thalamic reaction. In this study, we showed that all
IPs had a lesion within the Vim that matches exactly
with the radiosurgical planning. However, our results
also showed, to our knowledge for the first time, that
all of the NIPs but one had no or minimal lesions on
MRI, corresponding to a hyporesponse pattern. This
individual variability in the thalamic reactions to radi-
osurgery, although the procedure was strictly per-
formed in the same conditions, will need further
investigation.
Figure 3 Treatment plan (upper panels) and 12-month neuroimaging follow-up (lower panels)
The thalamic lesion matches exactly with the planned target (as outlined by the 65-Gy [50%] isodose line). Upper panels: Diffusion tensor imaging coronal
(A), T2-sagittal (B), and gadolinium-enhanced T1-weighted axial (C). Lower panels: Gadolinium-enhanced T1-weighted in coronal (D), sagittal (E), and axial (F)
planes.
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Several surgical strategies have been proposed over
the past decades for severe medically refractory tremor
and have transformed the outcome of this severely
disabling condition. These include radiofrequency
thermo-thalamotomy, DBS, and GK radiosurgery.
The advantage of DBS is that it can be performed
bilaterally. Today, thermo-thalamotomies are per-
formed unilaterally either by radiofrequency or LITT
(laser-induced thermal therapy) or HIFU (high-
intensity focused ultrasound). Both LITT and HIFU
are methods for a very early stage and require intrao-
perative (MRI) temperature monitoring. These 2
techniques are still investigational with limited expe-
rience in the literature and a lack of blinded assess-
ment and long-term evaluation.24–26
The radiobiological effect of radiosurgery is
unique. This delayed biological effect is completely
different from the acute physical thermocoagulation
effect. The circumscribed central necrotic lesion
(4-mm diameter) where the highest dose was deliv-
ered is surrounded by a nonnecrotic halo consisting
of vascular changes and astrocytogliosis.27,28 These
peripheral modifications may induce a larger thera-
peutic effect than thermolesions.28 This peripheral
effect may explain the sustained beneficial effect after
GKT reported in most studies.15,17 The very small size
of the residual lesion on long-term follow-up has led
some authors to discuss the possibility of a nonle-
sional effect of radiosurgery around the small necrotic
scar.27,28
This single-blind prospective study showed that
unilateral GKT allows a significant benefit for pa-
tients with medically refractory upper limb tremor
with both a reduction of the tremor score and an
improvement in ADL. The adverse events are rare
(2%) and usually transient. Long-term effects of
GKT in the present cohort will need to be examined
in follow-up studies. Future randomized studies com-
paring risk–benefit ratios for the different existing
surgical techniques from DBS to ablative surgery for
disabling medication-resistant tremors are warranted.
The present study shows that GKT may provide a
unique opportunity to improve ADL in a population
of elderly patients with disabling tremor or patients
not suitable to undergo a more invasive procedure.29
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